2013Medical Innovation of ChinaRequires access

The Efficacy of Valsartan Merger Indapamide in Treatment of Hypertension

Liu Jua

Open publisher page 0 citations

Abstract

Objective:To observe the efficacy,safety and feasibility of valsartan combined with indapamide treatment of essential hypertension. Method:118 patients with essential hypertension were randomly divided into a treatment group and the control group of 59 cases. Valsartan treatment group using valsartan combined with indapamide control group,effects were observed after 8 weeks.Result:Treatment group total effective rate was 91.5%,control group total effective rate was 78.0%,there was significant difference between the two groups meaning( P 0.05).Conclusion:Valsartan combined indapamide treatment of primary hypertension efficacy significantly fewer adverse reactions,safe and reliable,good compliance.

About this research paper

What this paper is about

Objective:To observe the efficacy,safety and feasibility of valsartan combined with indapamide treatment of essential hypertension. Method:118 patients with essential hypertension were randomly divided into a treatment group and the control group of 59 cases. Valsartan treatment group using valsartan combined with indapamide control group,effects were observed after 8 weeks.Result:Treatment group total effective rate was 91.5%,control group total effective rate was 78.0%,there was significant difference between the two groups meaning( P 0.05).Conclusion:Valsartan combined indapamide treatment of primary hypertension efficacy significantly fewer adverse reactions,safe and reliable,good compliance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the efficacy,safety and feasibility of valsartan combined with indapamide treatment of essential hypertension. Method:118 patients with essential hypertension were randomly divided into a treatment group and the control group of 59 cases. Valsartan treatment group using valsartan combined with indapamide control group,effects were observed after 8 weeks.Result:Treatment group total effective rate was 91.5%,control group total effective rate was 78.0%,there was significant difference between the two groups meaning( P 0.05).Conclusion:Valsartan combined indapamide treatment of primary hypertension efficacy significantly fewer adverse reactions,safe and reliable,good compliance.

Key concepts: Indapamide, Valsartan, Medicine, Essential hypertension, Adverse effect, Internal medicine, Pharmacology, Blood pressure

Related papers

Back to paper searchBrowse research topicsOriginal source
The Efficacy of Valsartan Merger Indapamide in Treatment of Hypertension — Research Paper | ScholarLens